mounjaro tirzepatide manufacturer

mounjaro tirzepatide manufacturer 2.5 mg / 0.5 ml Vial - dependent insulinotropic polypeptide (GIP) and glucagon FDA Says Compounded Tirzepatide Must

Name: mounjaro tirzepatide manufacturer 2.5 mg / 0.5 ml Vial - dependent insulinotropic polypeptide (GIP) and glucagon FDA Says Compounded Tirzepatide Must
Brand: actil.am
SKU: 27559285328
Price: 22.69 USD
Availability: InStock
Rating: 4.8631 (9 reviews)

SKU: 27559285328

4.9

USD22.69 USD42.69

Pay in 4 interest-free payments of $5.67 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 25 - Aug 30

Description

The number of weeks worth of doses remains the same regardless of how much water you add

Participants who took 2.4 mg of semaglutide weekly lost an average of 14.9% of their body weight over 68 weeks (about 16 months), compared to 2.4% in the placebo group

This product has not been evaluated by the FDA for compounded use

Clinical trials show non-diabetic individuals lose an average of 1022% of body weight over one year, with results varying based on genetics, starting weight, and lifestyle support